KP Tissue Inc faced a significant decline in its stock price, raising concerns among investors.
Yesterday, KP Tissue Inc (KPT.TO) experienced a sharp drop of 7.40%, closing at CA$11.26. This downturn marks a troubling moment for the company, which has recently been navigating a challenging market environment.
Investor takeaway: Investors should remain vigilant as KP Tissue's recent performance raises questions about its stability and future growth prospects.
Advertisement
KP Tissue Inc
KPT.TO
KPT.TO
KP Tissue Inc
WealthAwesomeMarket cap
$112.96M
P/E
12.8x
Div. yield
5.92%
Div. / share
$0.72
52W high
$13.39
52W low
$8.54
1W change
-12.85%
Beta
0.39
Analyst Price Targets
Based on analyst covering KPT · as of Sep 17, 2026
Wall Street analysts forecast KPT stock price to rise 16.6% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$13.13
+16.6% Upside
Current Price
C$11.26
Last close
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on KPT's historical volatility
30-Day Vol
25.6%
Annualized
90-Day Vol
20.4%
Annualized
Trend (90d)
-50.0%
Annualized drift
90d Mean
C$9.42
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$10.61 | C$9.71 – C$11.59 |
| 60 trading days | C$10.00 | C$8.82 – C$11.32 |
| 90 trading days | C$9.42 | C$8.08 – C$10.97 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
KP Tissue Inc's stock fell by 7.40% yesterday
With a market cap of CA$112.96 million, the decline reflects investor concerns over the company's future profitability.
Bull case
Despite yesterday's decline, KP Tissue has shown strong profitability in previous quarters. This suggests there’s potential for recovery if market conditions improve.
Bear case
The significant drop in stock price could signal deeper issues within the company or the industry, which may persist and affect future performance.
Market Reaction
Advertisement
The 7.40% drop in KP Tissue's stock price yesterday reflects investor apprehension about the company's current standing in the market. With no recent news to explain the decline, market analysts are left speculating about potential underlying issues.
Company Performance Overview
KP Tissue has previously reported strong financial results, including a 14.6% increase in adjusted EBITDA in Q1 2026. However, the recent stock performance raises questions about whether this momentum can be sustained. Investors may want to monitor upcoming earnings reports for more insights into the company's trajectory. For more details, visit the KP Tissue stock page.
Looking Ahead
As KP Tissue prepares for its upcoming shareholder meeting and potential future announcements, investors will be keenly watching for any signals that could indicate a turnaround or further decline. Staying informed through updates on the KP Tissue stock page will be crucial for making informed investment decisions.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
